{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:28Z","timestamp":1753890688249,"version":"3.41.2"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant disorder, accompanied by multiple endocrine neoplasms of the parathyroid, pancreas, pituitary, and other neoplasms in the adrenal glands. However, in some cases, patients clinically diagnosed with MEN1 may be genotype-negative.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 56-year-old female was diagnosed with MEN1 based on a macroprolactinoma (19 mm in diameter), primary hyperparathyroidism, and a cortisol-producing adrenal adenoma, without a family history. At first appearance, she had a hemoglobin A1c of 12.0% and a fasting plasma glucose level of 16.3 mmol\/L (294 mg\/dL). She complained of headaches and had a history of prolactinoma at 28 years of age, with concomitant elevated prolactin 1102.0 \u03bcg\/L (ng\/mL). Insulin therapy was initiated for glucose management following the administration of an oral hypoglycemic agent. Additionally, cabergoline was initiated for due to the prolactinoma, resulting in a normalized prolactin level. Thereafter, medication for diabetes could be withdrawn. Subsequently, surgery was performed for primary hyperparathyroidism and the cortisol-producing adrenal adenoma, which was consistent with the preoperative diagnosis. Additionally, a thyroid tumor resected with primary hyperparathyroidism revealed to be invasive papillary thyroid carcinoma (PTC). Target gene testing revealed a negative genotype for <jats:italic>MEN1<\/jats:italic> gene, with only one common polymorphism that was non-pathogenic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Genotype-negative MEN1 typically has a favorable clinical course without a third primary MEN1 manifestation. However, the present case had a symptomatic macroprolactinoma with an apparent elevated glucose level and three manifestations of tumors (pituitary, parathyroid, and adrenal) with invasive PTC, and a delayed diagnosis could have caused crucial deterioration. Clinicians should pay attention to the clinical features of MEN1 including glucose intolerance. In such cases, the treatment of endocrine disorders can lead to the normalization of the glucose level.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1498991","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T04:30:00Z","timestamp":1733977800000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing\u2019s syndrome accompanied by hyperglycemia: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Haremaru","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Sekikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1183297","article-title":"Expressions of Cushing\u2019s syndrome in multiple endocrine neoplasia type 1","volume":"14","author":"Simonds","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0456","article-title":"Bone phenotypes in multiple endocrine neoplasia type 1: survey on the MEN1 Florentine database","volume":"11","author":"Marini","year":"2022","journal-title":"Endocr Connect"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ18-0445","article-title":"Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing\u2019s syndrome","volume":"66","author":"Tsurutani","year":"2019","journal-title":"Endocr J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ16-0500","article-title":"Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism","volume":"64","author":"Tsurutani","year":"2017","journal-title":"Endocr J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ21-0439","article-title":"Increased glycated albumin levels in patients with acromegaly related to glucose fluctuation caused by growth hormone excess but not albumin metabolism","volume":"69","author":"Taguchi","year":"2022","journal-title":"Endocr J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01484-2","article-title":"Hidden hypercortisolism: a too frequently neglected clinical condition","volume":"44","author":"Giovanelli","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612676","article-title":"Diabetes mellitus secondary to endocrine diseases: an update of diagnostic and treatment particularities","volume":"24","author":"Popoviciu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12314","article-title":"Headache and pituitary disease: a systematic review","volume":"79","author":"Kreitschmann-Andermahr","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1507\/endocrj.ej12-0071","article-title":"Delay in the diagnosis of multiple endocrine neoplasia type 1: typical symptoms are frequently overlooked","volume":"59","author":"Yamazaki","year":"2012","journal-title":"Endocr J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13306","article-title":"Japanese clinical practice guideline for diabetes 2019","volume":"11","author":"Araki","year":"2020","journal-title":"J Diabetes Investig"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03570.x","article-title":"Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers","volume":"71","author":"Hattori","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0074","article-title":"Cardiovascular risk factors in mild adrenal autonomous cortisol secretion in a Caucasian population","volume":"11","author":"Adamska","year":"2022","journal-title":"Endocr Connect"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"key":"B17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41574-023-00916-2","article-title":"Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"20","author":"Petersenn","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B19","article-title":"Normocalcemic Hyperparathyroidism","volume-title":"StatPearls","author":"Stephen","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.humpath.2018.03.016","article-title":"Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma","volume":"77","author":"Kitawaki","year":"2018","journal-title":"Hum Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ17-0456","article-title":"New diagnostic criteria of adrenal subclinical Cushing\u2019s syndrome: opinion from the Japan Endocrine Society","volume":"65","author":"Yanase","year":"2018","journal-title":"Endocr J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12902-015-0041-2","article-title":"Novel MEN 1 gene findings in rare sporadic insulinoma\u2013a case control study","volume":"15","author":"Jyotsna","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-10-0028","article-title":"MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases","volume":"17","author":"Corbo","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2020.04.067","article-title":"Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies","volume":"169","author":"Pieterman","year":"2021","journal-title":"Surgery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00533","article-title":"The importance of an early and accurate MEN1 diagnosis","volume":"9","author":"de Laat","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luad078","article-title":"A novel pathogenic MEN1 gene variant identified in a family with multiple pancreatic neuroendocrine tumors","volume":"1","author":"Horikoshi","year":"2023","journal-title":"JCEM Case Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081895","article-title":"Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy","volume":"10","author":"Marini","year":"2021","journal-title":"Cells"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.3.503","article-title":"A case of multiple endocrine neoplasia type 1 combined with papillary thyroid carcinoma","volume":"49","author":"Kim","year":"2008","journal-title":"Yonsei Med J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i3.1032","article-title":"Multiple endocrine neoplasia type 1 combined with thyroid neoplasm: A case report and review of literatures","volume":"10","author":"Xu","year":"2022","journal-title":"World J Clin Cases"},{"key":"B31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4158\/EP.14.5.595","article-title":"Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation","volume":"14","author":"Alzahrani","year":"2008","journal-title":"Endocr Pract"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02563.x","article-title":"Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose","volume":"65","author":"McCallum","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2265.2011.04166.x","article-title":"Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers","volume":"76","author":"van Wijk","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-1-1","article-title":"How hyperglycemia promotes atherosclerosis: molecular mechanisms","volume":"1","author":"Aronson","year":"2002","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications","volume":"26","author":"Dal Canto","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg Feb"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Med (Baltimore)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1215","article-title":"Serum prolactin concentrations determine whether they improve or impair \u03b2-cell function and insulin sensitivity in diabetic rats","volume":"27","author":"Park","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13098-015-0094-4","article-title":"Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline","volume":"7","author":"Pala","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13369","article-title":"Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma","volume":"12","author":"Igata","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e4818","DOI":"10.1097\/MD.0000000000004818","article-title":"Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial","volume":"95","author":"Bahar","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15118","article-title":"Higher risk of incident diabetes among patients with primary hyperparathyroidism","author":"Zhang","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123115","article-title":"Epidemiology and management of hypertension and diabetes mellitus in patients with mild autonomous cortisol secretion: A review","volume":"11","author":"Araujo-Castro","year":"2023","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1234","article-title":"Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing\u2019s syndrome in obese patients","volume":"48","author":"Sahin","year":"2009","journal-title":"Intern Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267732","article-title":"Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression","volume":"17","author":"Kubo","year":"2022","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1498991\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T04:30:03Z","timestamp":1733977803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1498991\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":45,"alternative-id":["10.3389\/fendo.2024.1498991"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1498991","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"article-number":"1498991"}}